bioceramic based intracanal medication
PreclinicalSmall molecule
bioceramic based intracanal medication is one of 47 small molecule programs targeting Post Operative Pain. It is currently in Preclinical.
1
Indications
2
Total Trials
1
Active Trials
46
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
64 competitors in Post Operative Pain
#DrugCompanyPhaseTrials
1Marcaine
IInnocoll
Approved
Advil
KKenvue Brands
Approved
Tylenol
KKenvue Brands
Approved
Oxycontin
PProtega
Approved
Epsom Salt
FFresenius Kabi USA, LLC
Approved
Suboxone
IIndivior Inc.
Approved
Achromycin V
WWyeth-Lederle Vaccines
Approved
EXPAREL
Pacira Pharmaceuticals, IncApproved
Cyklokapron
JJ Molner
Phase 3
Bupivacain
IIstanbul University
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Post Operative Pain2 trials
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMinia University